Superstring Capital Management’s Boundless Bio BOLD Stock Holding History

Superstring Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$138K	Buy	+55,356	New	+$85.2K	0.09%	30

Other funds holding BOLD

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Superstring Capital Management's BOLD Position: Q2 2026 in Review

Superstring Capital Management opened a new position in Boundless Bio (BOLD) in Q2 2026: 55,356 shares worth $138K. The stake represents 0.09% of the portfolio and ranks #30 among its holdings.

40 funds tracked by Wall St. Rank hold BOLD as of Q2 2026.

Superstring Capital Management held 55,356 shares of Boundless Bio worth $138K as of Q2 2026.
Boundless Bio was a new Superstring Capital Management position in Q2 2026.
Boundless Bio made up 0.09% of Superstring Capital Management's portfolio in Q2 2026, its #30 holding.
40 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.